cover
Article Per Year (5 Year)
All
Home Page
OAI Link
Editorial Team
Contact
Reviewer
Google Scholar
Contact Name
-
Contact Email
-
Phone
-
Journal Mail Official
-
Editorial Address
-
Location
Kab. sleman,
Daerah istimewa yogyakarta
INDONESIA
JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice)
Published by Universitas Gadjah Mada
ISSN : 20888139     EISSN : 24432946     DOI : -
Core Subject : Health,
Health Professions Medicine & Pharmacology Public Health
JMPF is the first open access journal in Indonesia specialized in both research of pharmaceutical management and pharmacy practice. Articles submitted in JMPF are peer reviewed, we accept review articles and original research articles with no submission/publication fees. JMPF receives manuscripts in both English (preferably) and Indonesian Language (Bahasa Indonesia) with abstracts in bilingual, both Indonesian and English. JMPF is also open for various fields such as pharmaceutical management, pharmacoeconomics, pharmacoepidemiology, clinical pharmacy, community pharmacy, social pharmacy, pharmaceutical marketing, goverment policies related to pharmacy, and pharmaceutical care.
Arjuna Subject : -
Articles 4 Documents
 1 
Search results for , issue "Vol 12, No 3" : 4 Documents clear
Pemanfaatan Sistem Informasi Geografis untuk Analisa Pola Distribusi Apotek di Kota dan Kabupaten Malang Eva Monica; Kestrilia Rega Prilianti; Indah Lestari; Endhirayanti Caesarika
JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice) Vol 12, No 3
Publisher : Faculty of Pharmacy, Universitas Gadjah Mada

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22146/jmpf.67445

Abstract

Health service facilities, especially pharmacies, play an important role in meeting the community's need for health support. The large number of pharmacies in Malang City and Regency is currently considered to be able to cause high competition between pharmacies so that the geographic information system was chosen to see how the distribution of pharmacies is reviewed based on the population in each sub-district and the number of health facilities scattered in Malang. The purpose of this study was to determine the distribution pattern of pharmacies and their ratio to the total population density and health facilities in Malang City and Regency. The method used in this research is to collect data in the form of coordinate points of pharmacies and health facilities, followed by processing data in the form of a T index and using Arcgis 10.3 software to visualize it in the form of a map. In the analysis of the distribution of pharmacies in Malang City, the five sub-districts showed uniform or evenly distributed results, while in Malang District, out of 33 sub-districts, only 17 districts had a uniform pattern. Based on the ratio of pharmacies and the population of Kedungkandang District, it can be said to have the best accessibility, namely 1:1.010 (14:100,000), which has met the requirements set by the Ministry of Health and WHO. While the other 4 sub-districts in Malang City have met the requirements for pharmacists according to the Ministry of Health but have not met the requirements for pharmacists according to WHO. In Malang Regency, the standard of pharmacy service in terms of the ratio of the availability of pharmacies to the population has not been met, only 4 sub-districts have ratios that meet the requirements of the Ministry of Health but have not met the needs of WHO. The results of the ratio of pharmacies that were reviewed based on the number of health facilities showed that out of five sub-districts in Malang City, four other sub-districts namely Kedungkandang, Blimbing, Lowokwaru and Klojen had a ratio with a good category, while Sukun District had a very good ratio. In Malang Regency, 17 sub-districts have a very good ratio, 3 sub-districts show a good ratio value, 12 sub-districts have a ratio value of 0-0.9, indicating that the number of pharmacies in the sub-district is less than the number of health facilities.
Potentially Inappropriate Medication (PIMs) Identification Using 2019 Beers Criteria at a Secondary Referral Hospital in Jakarta Nurhasnah Nurhasnah; Daniek Viviandhari; Riska Nur Sakinah; Desi Wulandari
JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice) Vol 12, No 3
Publisher : Faculty of Pharmacy, Universitas Gadjah Mada

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22146/jmpf.71246

Abstract

Drug information about Potentially Inappropriate Medications (PIMs) for elderly inpatients based on Beers 2019 is still limited in Indonesia. This study aimed to identify the incidence of PIMs using the 2019 Beers criteria in elderly patients and determine the factors associated with the incidence of PIMs. This research was observational with a cross-sectional approach. Data collection was carried out in the medical records section of a secondary referral hospital in Jakarta during August and September 2019. The number of samples was calculated using a sample size calculator, and data were obtained from the medical records of inpatients for the period January 2018-December 2018. The sampling of medical records in was conducted with a non-probability sample with a purposive sampling technique. Inclusion criteria were medical records of inpatients aged 60 years or older. The exclusion criteria were patient medical records with incomplete data. The Beers 2019 criteria were used to identify PIMs. The results showed that from 325 medical records analyzed, PIMs were found in 122 (37.5%) elderly patients with a total incidence of 181 PIMs. Furosemide (25.4%) was the most common PIMs, followed by spironolactone (18.2%) and ranitidine (16%). The use of 10 medicines or more p<0.001, OR 4.26 95%CI (2.4-7.5) and a length of stay more than five days p=0.043 OR 1.65 95%CI (1.0- 2,6) was associated with a higher incidence of PIMs. However, age, gender, and the number of diagnoses were not significantly related to the incidence of PIMs. Health workers are advised to check serum creatinine in all hospitalized elderly patients and minimize the number of drugs used.
Cost Effectiveness Analysis (CEA) Strategi Terapi Anemia pada Pasien Penyakit Ginjal Kronis Nurfina Dian Kartikawati; Tri Murti Andayani; Dwi Endarti
JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice) Vol 12, No 3
Publisher : Faculty of Pharmacy, Universitas Gadjah Mada

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22146/jmpf.72614

Abstract

 Chronic kidney disease (CKD) is a condition in which the kidneys are unable to maintain a fluid balance of metabolic waste that is progressive, irreversible, and takes place slowly. Anemia is a complication of CKD that contributes to morbidity, mortality, quality of life of patients, as well as greater costs of care. This study aims to evaluate the differences in the effectiveness and cost of anemia therapy with epoetin in patients with chronic kidney disease. The study was conducted in an analytical-observational manner with a retrospective cohort design from the provider's perspective. The sample used was CKD patients with anemia who met the inclusion criteria for the period January - December 2020, data were taken from medical records and patient financial recapitulation. Statistical analysis was carried out on the effectiveness of anemia therapy with epoetin based on the achievement of clinical outcomes of increasing Hb values within 3 months and financing calculated based on direct medical costs. A total of 113 patients met the inclusion criteria, consisting of 96 patients in the epoetin alpha group and 17 patients in the epoetin beta group. The percentage of achieving therapeutic targets in the epoetin beta group was higher (11.76%) than in the epoetin alfa group (10.42%). The average increase in Hb in the EPO beta group was higher than in the EPO alpha group. The cost of epoetin for anemia treatment in the beta epoetin group (Rp 1,005,365) was lower than the epoetin alfa group (Rp 1,017,188). The ICER value obtained was IDR -125,966, indicating a cost savings of IDR 125,966 to increase 1% of the achievement of therapeutic targets for Hb values >10 g/dl. The cost of therapy with EPO beta is lower than EPO alpha and the achievement of Hb therapy targets is better in EPO beta than EPO alpha.
Keamanan Penggunaan Antiglukolan pada Pasien Rawat Inap Stroke Iskemik dengan Atrial Fibrilasi Juniarto Mende; Fita Rahmawati; Ika Puspitasari
JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice) Vol 12, No 3
Publisher : Faculty of Pharmacy, Universitas Gadjah Mada

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22146/jmpf.74893

Abstract

Atrial fibrillation can cause stroke due to blood stasis in left atrium which triggers thrombus formation and embolization to the brain. Administration of anticoagulants is used to prevent clot formation so as to prevent the occurrence of stroke, but on the other hand it is associated with the risk of bleeding side effects. This study aims to evaluate the safety of anticoagulants in ischemic stroke patients with atrial fibrillation. The study used a cross sectional design. Retrospective data were taken from the medical records of RSUP Dr. Sardjito, Yogyakarta period January 2018 to December 2020. The research subjects were ischemic stroke patients with atrial fibrillation. Evaluation of the safety of anticoagulants includes the number of major and minor bleeding events in each type of anticoagulant and the factors that influence the occurrence of bleeding. A total of 70 patients met the study inclusion criteria. Bleeding occurred in 41 cases (58,57%). Major bleeding was 28 patients (40%) and minor bleeding was 13 patients (18,57%). The most common anticoagulant that causes bleeding is warfarin. Multivariate test of the factors that influence the occurrence of bleeding in kidney failure (OR = 5,990; 95% Cl 2,002-17,920; p = 0,001). Monitoring the side effects of anticoagulants, especially warfarin is necessary. Pharmacists can play an important role in monitoring and preventing bleeding events by taking into account risk factors, especially kidney failure.

Page 1 of 1 | Total Record : 4

 1 

Filter by Year

2022 2022


Reset
Filter By Issues
All Issue Vol 13, No 3 (2023): IN PRESS Vol 13, No 2 Vol 13, No 1 Vol 12, No 4 Vol 12, No 4 (2022) Vol 12, No 3 Vol 12, No 2 Vol 12, No 1 Vol 1, No 3 Vol 11, No 4 Vol 11, No 3 Vol 11, No 2 Vol 11, No 1 Vol 10, No 4 Vol 10, No 3 Vol 10, No 2 Vol 10, No 1 Vol 9, No 4 Vol 9, No 3 Vol 9, No 2 Vol 9, No 1 Vol 8, No 4 Vol 8, No 3 Vol 8, No 2 Vol 8, No 1 Vol 7, No 4 Vol 7, No 3 Vol 7, No 2 Vol 7, No 1 Vol 6, No 4 Vol 6, No 3 Vol 6, No 2 Vol 6, No 1 Vol 5, No 4 Vol 5, No 4 Vol 5, No 3 Vol 5, No 3 Vol 5, No 2 Vol 5, No 1 Vol 4, No 4 Vol 4, No 3 Vol 4, No 2 Vol 4, No 1 Vol 3, No 4 Vol 3, No 3 Vol 3, No 2 Vol 3, No 1 Vol 2, No 4 Vol 2, No 3 Vol 2, No 2 Vol 2, No 1 Vol 1, No 4 Vol 1, No 2 Vol 1, No 1 More Issue